CompletedNot Applicable

Impact of Umbilical Cord Clamping Time on Infant Anemia

Turkey (Türkiye)65 participantsStarted 2017-12-21

Plain-language summary

This research was conducted to carry out the effect of umbilical cord clamping time on baby anemia.

Who can participate

Age range

19 Years – 35 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Apply for normal birth * Singleton pregnancy and live fetus * Cephalic presentation * Estimated birth weight between 2500-4000 grams * Birth rates \<5 * Women who received iron support during pregnancy * Haemoglobin level ≥ 11 gr/dL * No systemic disease or pregnancy complication that may pose a risk for postpartum bleeding. * Neonates who don't need for resuscitation after birth * Babies who did not receive iron supplements up to the 4th month after birth were included. Exclusion Criteria: * Pregnant women who refuse to participate in the research * Neonates who need for resuscitation after birth * Babies who receive iron supplements up to the 4th month after birth were excluded.

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Neonatal Haematocrit Value at 48th Hours of Life

Timeframe: 48th hours after birth

Neonatal Bilirubin Value at 48th Hours of Life

Timeframe: 48th hours after birth

Phototherapy Requirement Rates due to Hyperbilirubinemia

Timeframe: 3 or 14 days of age

Haemoglobin Values of 4 Month Infants

Timeframe: Infants' 4th month of age

Haematocrit Values of 4 Month Infants

Timeframe: Infants' 4th month of age

Diagnosis of Anemia Rates of 4 Month Infants

Timeframe: Infants' 4th month of age

Trial details

NCT IDNCT04463485

SponsorMersin University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2018-08-30

View on ClinicalTrials.gov More Third Stage of Labor trials

Who can participate

Age range

19 Years – 35 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

What they're measuring

Neonatal Haematocrit Value at 48th Hours of Life

Timeframe: 48th hours after birth

Neonatal Bilirubin Value at 48th Hours of Life

Timeframe: 48th hours after birth

Phototherapy Requirement Rates due to Hyperbilirubinemia

Timeframe: 3 or 14 days of age

Haemoglobin Values of 4 Month Infants

Timeframe: Infants' 4th month of age

Haematocrit Values of 4 Month Infants

Timeframe: Infants' 4th month of age

Diagnosis of Anemia Rates of 4 Month Infants

Timeframe: Infants' 4th month of age